Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
about
Galactomannan detection for invasive aspergillosis in immunocompromised patientsGalactomannan detection for invasive aspergillosis in immunocompromized patientsHow to manage aspergillosis in non-neutropenic intensive care unit patientsGenetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipientsIn vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary aspergillosisNeutrophils mediate maturation and efflux of lung dendritic cells in response to Aspergillus fumigatus germ tubes.Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland.Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanismPeroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™.A role for the unfolded protein response (UPR) in virulence and antifungal susceptibility in Aspergillus fumigatus.Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006Aspergillus PCR: one step closer to standardization.Factors associated with mortality in transplant patients with invasive aspergillosisInfluence of polymorphisms in innate immunity genes on susceptibility to invasive aspergillosis after stem cell transplantationEarly molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia.Fungal infections in transplant and oncology patients.First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.Role of Aspergillus fumigatus DvrA in host cell interactions and virulenceMyeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infectionBone suppression increases the visibility of invasive pulmonary aspergillosis in chest radiographsImpact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosisAntifungal clinical trials and guidelines: what we know and do not knowRandomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.Reduced mortality after allogeneic hematopoietic-cell transplantation.Primary renal aspergillosis and renal stones in both kidneys associated with hematopoietic stem cell transplant.Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in SpainAspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes.Divergent Protein Kinase A isoforms co-ordinately regulate conidial germination, carbohydrate metabolism and virulence in Aspergillus fumigatus.Ribosomal and mitochondrial DNA target for real-time PCR diagnosis of invasive aspergillosisReducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?Establishment and application of real-time quantitative PCR for diagnosing invasive aspergillosis via the blood in hematological patients: targeting a specific sequence of Aspergillus 28S-ITS2.Secondary antifungal prophylaxis in hematological malignancy patients with previous invasive fungal disease: a retrospective analysis.A risk prediction score for invasive mold disease in patients with hematological malignanciesEpidemiology of invasive fungal infections in the mediterranean areaClinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine.Efficacy of combination therapy of triazole and echinocandin in treatment of invasive aspergillosis: a systematic review of animal and human studiesCauses of death in a contemporary cohort of patients with invasive aspergillosisThe contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.
P2860
Q24186895-EF591285-8504-406B-84DC-18D8160E2773Q24240734-278A4A31-2FB5-49A0-A42F-335FDF52B913Q26999448-FEE3A806-B7E0-4C11-A884-5E82370914A2Q27312010-983D5534-52B0-4A73-8128-22CBD1682286Q28479237-66332D26-261F-40A5-A492-57FABEBB65A9Q30424239-D43903C0-B6EB-4964-AC85-0DD1D2E764CAQ30844091-C5A47F59-8350-4019-AC68-A83D3223C522Q30853962-F0CACCFD-7057-4454-9C35-38B980531EF8Q31037255-04D96F0C-D10B-4AEF-AB31-2072D2BB779FQ33398514-429A3F14-AA73-4CC7-AA2A-4E15B036AC56Q33689767-66674518-043B-4BBE-B83B-2165A52F516EQ33723583-EE6A2A9C-726B-4B55-BA75-7FEC27B4E99CQ33769584-FF0957B2-8755-448D-ACEB-4EEF4425F23EQ33867013-F426C462-B227-4804-8C7E-831E68148603Q33869448-43743DE9-5A26-4B5D-AC2D-9C1DAC37E3BAQ33893292-3800DA7B-8734-45B8-BAED-8E7B2AD6B850Q33896940-19C61F63-7C05-4F65-8D89-434DE0361E82Q34057414-FF03A220-1CB8-4B05-B0B2-9D6ED6C8AB70Q34177616-151D01BD-5FB3-48B6-A277-A42C3C551EEFQ34257883-BFD38EF9-B5D2-4829-86FB-667A39C8EE26Q34287044-64CC25E0-C436-4967-B6A8-E6ACAA1617CCQ34290034-142CC0E8-1894-4318-8D15-A8AFF189ADC6Q34400255-91E310E5-9A8F-427A-AAE3-34F0EB6C1264Q34450423-CEA928E4-BAF9-4A9F-85DF-03FD8E82C470Q34472861-6A84A464-13A4-4CAC-B3BD-4D660884BD90Q34501108-FAD806C0-7BC8-4126-88D1-C0868B0E81F6Q34549917-53365F36-CEF0-4164-968F-79C6742FFCBFQ34559978-56B2713D-0045-48B6-9219-BCFF2DA6DC51Q34727553-79E72149-6F53-433F-B6B9-490073A0A3B0Q34741130-5708AAFC-23F0-4122-B1FB-564225A5787AQ34743469-96DE197A-000B-4DDC-B1D6-9F734EF42CCFQ34750807-28641EF8-93EB-40F1-A6EE-379697E043FEQ34756973-5CDE21E8-44D8-4E25-975E-D37841FDA6B2Q35005712-E1810160-4AB5-40D6-BCA3-DC9497B7A5EFQ35010686-F83CC527-047F-4CA4-AFC1-104057D87EDFQ35026481-B8D60B0E-F29B-4FC4-924D-0B66DEC8273EQ35075750-55355A46-F33A-43E1-9127-C41654EC3036Q35113648-94697FD4-5801-48D2-98DD-AD7A186C1013Q35213770-AD8D2A0C-F28D-4384-A7F3-9720F29ED03EQ35235892-F914F738-122C-48D0-8F29-C13D79494902
P2860
Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Invasive aspergillosis followi ...... ors associated with mortality.
@ast
Invasive aspergillosis followi ...... ors associated with mortality.
@en
type
label
Invasive aspergillosis followi ...... ors associated with mortality.
@ast
Invasive aspergillosis followi ...... ors associated with mortality.
@en
prefLabel
Invasive aspergillosis followi ...... ors associated with mortality.
@ast
Invasive aspergillosis followi ...... ors associated with mortality.
@en
P2093
P356
P1476
Invasive aspergillosis followi ...... ors associated with mortality.
@en
P2093
Arlo Upton
Katharine A Kirby
Kieren A Marr
Paul Carpenter
P304
P356
10.1086/510592
P407
P577
2007-01-09T00:00:00Z